Cargando…

Exploring Novel Molecular Targets for the Treatment of High-Grade Astrocytomas Using Peptide Therapeutics: An Overview

Diffuse astrocytomas are the most aggressive and lethal glial tumors of the central nervous system (CNS). Their high cellular heterogeneity and the presence of specific barriers, i.e., blood–brain barrier (BBB) and tumor barrier, make these cancers poorly responsive to all kinds of currently availab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guidotti, Giulia, Brambilla, Liliana, Rossi, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072800/ https://www.ncbi.nlm.nih.gov/pubmed/32093304 http://dx.doi.org/10.3390/cells9020490

Ejemplares similares

Withaferin A Inhibits Nuclear Factor-κB-Dependent Pro-Inflammatory and Stress Response Pathways in the Astrocytes
por: Martorana, Francesca, et al.
Publicado: (2015)

Dysregulation of Astrocytic HMGB1 Signaling in Amyotrophic Lateral Sclerosis
por: Brambilla, Liliana, et al.
Publicado: (2018)

Tumor Necrosis Factor Alpha in Amyotrophic Lateral Sclerosis: Friend or Foe?
por: Guidotti, Giulia, et al.
Publicado: (2021)

Molecular Aberrations Stratify Grade 2 Astrocytomas Into Several Rare Entities: Prognostic and Therapeutic Implications
por: Internò, Valeria, et al.
Publicado: (2022)

Inhibition of formyl peptide receptor in high-grade astrocytoma by CHemotaxis Inhibitory Protein of S. aureus
por: Boer, J C, et al.
Publicado: (2013)

Gene Expression Profiling in Human High-Grade Astrocytomas
por: Liu, Zhongyu, et al.
Publicado: (2011)

Prognostic significance of multiple kallikreins in high-grade astrocytoma
por: Drucker, Kristen L., et al.
Publicado: (2015)

Capturing the Molecular and Biological Diversity of High-Grade Astrocytoma in Genetically Engineered Mouse Models
por: Chow, Lionel M.L., et al.
Publicado: (2012)

Potential roads for reaching the summit: an overview on target therapies for high-grade gliomas
por: Giotta Lucifero, Alice, et al.
Publicado: (2020)

Long-term molecular changes in WHO grade II astrocytomas following radiotherapy
por: Yue, Wei-Ying, et al.
Publicado: (2012)

Potential Canonical Wnt Pathway Activation in High-Grade Astrocytomas
por: Schüle, Rebecca, et al.
Publicado: (2012)

Differentiation of Low-Grade Astrocytoma From Anaplastic Astrocytoma Using Radiomics-Based Machine Learning Techniques
por: Chen, Boran, et al.
Publicado: (2021)

Transcriptional Analysis of Aggressiveness and Heterogeneity across Grades of Astrocytomas
por: Wang, Chunjing, et al.
Publicado: (2013)

Low-Grade Astrocytoma Causing Dural and Calvarial Destruction
por: Belfquih, Hatim, et al.
Publicado: (2023)

Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives
por: Cabri, Walter, et al.
Publicado: (2021)

Pediatric high-grade astrocytomas: a distinct neuro-oncological paradigm
por: Gerges, Noha, et al.
Publicado: (2013)

Relationship Between Cytogenetic Complexity and Peritumoral Edema in High-Grade Astrocytoma
por: Jeong, Kyung-Ho, et al.
Publicado: (2016)

Significance of Amphiregulin (AREG) for the Outcome of Low and High Grade Astrocytoma Patients
por: Steponaitis, Giedrius, et al.
Publicado: (2019)

Gene Expression Profiling of Chemokines and Their Receptors in Low and High Grade Astrocytoma
por: Sharma, Ira, et al.
Publicado: (2017)

Immunotherapy: A Potential Approach for High-Grade Spinal Cord Astrocytomas
por: Hu, Jie, et al.
Publicado: (2021)

Novel insight into histological and molecular astrocytoma, IDH‐mutant, Grade 4 by the updated WHO classification of central nervous system tumors
por: Chen, Wenlin, et al.
Publicado: (2023)

Diffusion differences between pilocytic astrocytomas and grade II ependymomas
por: Pavlisa, Goran, et al.
Publicado: (2011)

EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas
por: Tsai, Wen-Chiuan, et al.
Publicado: (2013)

Comparative transcriptomics reveals similarities and differences between astrocytoma grades
por: Seifert, Michael, et al.
Publicado: (2015)

GFAP expression is influenced by astrocytoma grade and rs2070935 polymorphism
por: Sereika, Mantas, et al.
Publicado: (2018)

RNA sequencing data of different grade astrocytoma cell lines
por: de Sousa, Juliana Ferreira, et al.
Publicado: (2020)

DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas
por: Jeyapalan, Jennie N., et al.
Publicado: (2016)

Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas
por: Kepe, Vladimir, et al.
Publicado: (2018)

Textiloma Mimicking a Recurrent High-Grade Astrocytoma: A Case Report
por: Jaramillo-Jiménez, Esteban, et al.
Publicado: (2020)

Systemic Metastasis of Pediatric Diffuse High-grade Astrocytoma: A Case Report
por: CHIBA, Kentaro, et al.
Publicado: (2023)

Infantile/Congenital High-Grade Gliomas: Molecular Features and Therapeutic Perspectives
por: Ceglie, Giulia, et al.
Publicado: (2020)

Molecularly targeted treatment of recurrent anaplastic astrocytoma – a case report
por: Yalamanchi, Ashna, et al.
Publicado: (2021)

Cell-Penetrating Peptides as Valuable Tools for Nose-to-Brain Delivery of Biological Drugs
por: De Martini, Lisa Benedetta, et al.
Publicado: (2023)

Proliferation and aneusomy predict survival of young patients with astrocytoma grade II
por: Wessels, P H, et al.
Publicado: (2003)

Anaphylaxis to gadobutrol and gadoterate meglumine in a patient with low grade astrocytoma
por: Montalvo, Juan Manuel Escobar, et al.
Publicado: (2014)

Magnetic Resonance Spectroscopy for Prediction of Grades of Diffusely Infiltrating Intracranial Astrocytomas
por: Abu, Obaida, et al.
Publicado: (2020)

The Role of Liquid Biopsy in the Diagnosis and Prognosis of WHO Grade 4 Astrocytoma
por: Halawa, Taher, et al.
Publicado: (2023)

Overview of Nrf2 as Therapeutic Target in Epilepsy
por: Carmona-Aparicio, Liliana, et al.
Publicado: (2015)

Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification
por: Ren, Tong, et al.
Publicado: (2016)

Molecular and Cellular Mechanisms of Human Astrocytoma Progression: Advances in Knowledge to Reach Therapeutic Horizons
por: Comincini, Sergio
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tn2j5i57288pfdek8bj93uqafk